Comparison of antimicrobial activity between ceftolozane–tazobactam and ceftazidime–avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa

International Journal of Infectious Diseases

Rania El-Lababidi¹  Ahmad Nusair²  Mohammad Mooty²  Maria-Fernanda Bonilla²  Lysettee Cardona²  Laila AbdelWareth³  Hashim Elsayed³  Karen Lawlor³  Imran Mirza³  Adnan Alatoom³ 

[1] Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Al-Maryah Island, Abu Dhabi, United Arab Emirates;Medical Subspecialties Institute, Department of Infectious Diseases, Cleveland Clinic Abu Dhabi, Al-Maryah Island, Abu Dhabi, United Arab Emirates;Pathology and Laboratory Medicine Institute, Clinical Microbiology Section, Cleveland Clinic Abu Dhabi, Al-Maryah Island, Abu Dhabi, United Arab Emirates;

关键词: Gram-negative bacteria;    Multidrug resistance;    Ceftolozane–tazobactam;    Ceftazidime–avibactam;    carbapenem-resistant Enterobacteriaceae (CRE);   

DOI  :  10.1016/j.ijid.2017.06.007

来源: DOAJ

【 授权许可】

Unknown